These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8354089)

  • 21. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The source of endogenous digitalis-like substance in normal pregnancy].
    Gao S; Chen Z; Xu Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):539-41. PubMed ID: 10806730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of plasma level of neuropeptide Y in patients with pregnancy induced hypertension].
    Jin L; Wang C
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):206-8. PubMed ID: 11783361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioreceptor assay for the measurement of endogenous digitalis-like factors using membrane particulate fraction of human placenta and 125I-digoxin: comparison with RIA method.
    Cocci F; Clerico A; Paci A; Piras F; Del Chicca MG; Ciarimboli G; Strigini F; Moggi G
    J Nucl Med Allied Sci; 1990; 34(1):24-8. PubMed ID: 2384821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in blood oxytocin levels in cases of pregnancy induced hypertension].
    Gu H; Rong L; Sha JY
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):268-70, 316. PubMed ID: 7956547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the carrier protein of digoxin-like immunoreactive substance in plasma.
    Montali U; Balzan S; Ghione S
    J Hypertens Suppl; 1987 Dec; 5(5):S299-302. PubMed ID: 3481818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies.
    Loğoğlu G; Erdoğan S; Ozgünen FT; Doğan A; Ozgünen T; Kadayifçi O
    Int J Gynaecol Obstet; 1993 Nov; 43(2):137-43. PubMed ID: 7905428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripartum changes in free and protein-bound digoxinlike immunoreactive factor.
    Jakobi P; Kol S; Weissman A; Krivoy N
    J Reprod Med; 1992 Feb; 37(2):127-9. PubMed ID: 1538354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension.
    Kaminski K; Rechberger T
    Am J Obstet Gynecol; 1991 Sep; 165(3):733-6. PubMed ID: 1892203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in plasma endothelin-1 and lipid peroxidate levels and amount of superoxidate dismutase in red blood cell in patients with pregnancy-induced hypertension].
    Liang X; Lin Y; Cheng Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):220-2. PubMed ID: 8758777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s).
    Phelps SJ; Cochran EB; Gonzalez-Ruiz A; Tolley EA; Hammond KD; Sibai BM
    Am J Obstet Gynecol; 1988 Jan; 158(1):34-9. PubMed ID: 3337179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum digoxin-like substances in pregnancy-induced hypertension.
    Poston L; Morris JF; Wolfe CD; Hilton PJ
    Clin Sci (Lond); 1989 Aug; 77(2):189-94. PubMed ID: 2548800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal endoxins and complications of pregnancy.
    Goodlin RC; Makowski EL
    West J Med; 1988 May; 148(5):590-2. PubMed ID: 2845675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes of plasma p-selectin and nitric oxide in patients with pregnancy induced hypertension].
    Chen J; Lin Y; Wang C
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):12-4. PubMed ID: 11778535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Examining consecutively serum leptin levels in normal pregnant and pregnancy-induced hypertension women].
    Peng P; Li W; Jiang Y; Qiao L; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):529-32. PubMed ID: 12411012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in plasma endothelin level in pregnancy-induced hypertension with relation to its severity].
    Zhang AC; Li YR; Wang HJ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):2-4, 58. PubMed ID: 8033619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The changes of plasma nitric oxide in patients with pregnancy induced hypertension].
    Li L; Chen Z; Xu Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):454-7. PubMed ID: 9275434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.